The Development and Feasibility of a Novel Electronic Patient-Reported Outcome Measures (Eproms) Questionnaire in patients with penile cancer

• Published in: Clinical genitourinary cancer 2024-10, Vol.22 (5), p.102168, Article 102168
• Main Authors: Adegboye, Oluwatobi, Churchill, James, Moorjani, John, Johnson, Helen, Capper, Sharon, Booker, Jane, Parnham, Arie, Lau, Maurice, Sangar, Vijay, Faivre-Finn, Corinne
• Format: Article
• Language: English
• Subjects: Electronic patient-reported outcomes measure; ePROMs; Feasibility; Patient-reported outcome measures; PROMs; Service evaluation
• ISSN: 1558-7673; 1938-0682; 1938-0682
• DOI: 10.1016/j.clgc.2024.102168

Penile cancer (PeCa) is a rare cancer with surgical options that affect patients’ quality-of-life. Patient-reported outcome measures (PROMs) are uncommonly utilized in this cohort despite their several patient-centered benefits and there are recommendations to further digitalize PROMs. This prospective, population-based study aimed to report the development and feasibility of a novel electronic patient-reported outcome measures (ePROMs) questionnaire for patients with PeCa. A novel ePROMs questionnaire was developed and sent to patients 3 days before outpatient clinic appointments. The questionnaire included up to 30 items on patient symptomology and quality-of-life, including a self-reported quality-of-life score (rated 0 being worst and 100 being best). Data were collected for patients followed up between August 2021 and May 2022. The primary feasibility outcomes, adherence and engagement, were measured by response and drop-out rates. Differences in responders and nonresponders were also ascertained. Secondary outcomes explored the clinical utility of the questionnaire. Responders were subcategorized into 3 groups: circumcision (Ci), partial penectomy (PP) or total penectomy (TP) and differences were analyzed. This study was approved by the local Trust Governance Panel, including for ethical considerations. 220 adult males were sent ePROMs questionnaires, and 141 (64%) responded initially. The mean dropout rate of subsequent questionnaires was 56%. The maximum number of questionnaires sent to and completed by a patient was 8 (n = 1). Nonresponders were older (P < .0001), with poorer performance status (P < .0001) and lower body mass index (P = .0288). TP patients reported the lowest median quality-of-life score 68.50 (8-99), followed by the Ci group (72.0, 37-94) and the PP group (76.0, 10-99). Patients initially engaged and adhered to the ePROMs questionnaire but struggled to maintain this over time. Clinical data gathered by the questionnaire may be utilized to inform patient care. The questionnaire requires additional validation, research, and education. This study reports the development and feasibility of a novel electronic patient-reported outcome measures questionnaire for patients with penile cancer. 220 adult males were sent questionnaires, and 141 (64%) responded initially. The mean dropout rate of subsequent questionnaires was 56%, displaying that over time patients struggled to maintain adherence and engagement. The questionnaire requires add